BMC Cancer

official impact factor 3.15
Search for
Advanced search
BMC Cancer
Tools
Share this article
Open Access Highly Access Email this article to a friend

HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy

Jessica N McAlpine*, Kimberly C Wiegand, Russell Vang, Brigitte M Ronnett, Anna Adamiak, Martin Köbel, Steve E Kalloger, Kenneth D Swenerton, David G Huntsman, C B Gilks and Dianne M Miller

BMC Cancer 2009, 9:433 doi:10.1186/1471-2407-9-433

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.